[Corrigendum] S100A8 facilitates cholangiocarcinoma metastasis via upregulation of VEGF through TLR4/NF‑κB pathway activation
Affiliations: State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Centre for Nanomedicine, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, P.R. China, Oncology Department, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China, Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, P.R. China
- Published online on: February 6, 2020 https://doi.org/10.3892/ijo.2020.4977
- Pages: 1046-1046
Copyright : © Pan et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Int J Oncol 56: [Related article:] 101-112, 2020; DOI: 10.3892/ijo.2019.4907
Subsequently to the publication of the above article, the authors have realized that, in the Abstract on p. 101, line 12 and in the fourth sentence, "S100A8" was erroneously written as "S100A6". The sentence in question should have read as follows: "Furthermore, both in vitro and in vivo experiments revealed that overexpression of S100A8 promoted, while S100A8 knockdown attenuated, the migration and metastasis of CCA cells."
The authors regret that this error was not corrected before the article went to print, and apologize for any inconvenience caused.